Tags

Type your tag names separated by a space and hit enter

Topical therapy of alopecia areata with squaric acid dibutylester.
J Am Acad Dermatol. 1984 Mar; 10(3):447-50.JA

Abstract

The efficacy of the topical allergen squaric acid dibutylester (SADBE) was investigated in the treatment of twenty-six patients with alopecia areata or alopecia totalis. The patients had their disease for a mean duration of 8.3 years (range, 3 months to 27 years). Sensitization was attempted with 2% SADBE in acetone. Five individuals could not be sensitized. The twenty-one sensitized patients were treated with topical applications of 0.001% to 1.0% SADBE in acetone adjusted to produce and maintain dermatitis for an average of 21 weeks. Eleven (52%) had excellent responses consisting of complete regrowth in six and cosmetically acceptable regrowth in five. The average treatment time for regrowth was 11 weeks (range, 5-20 weeks). Ten (48%) had no clinical response after an average of 19 weeks of therapy (range, 4-42 weeks). Topical SADBE is an effective therapy for some patients with long-standing alopecia areata.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

6725657

Citation

Case, P C., et al. "Topical Therapy of Alopecia Areata With Squaric Acid Dibutylester." Journal of the American Academy of Dermatology, vol. 10, no. 3, 1984, pp. 447-50.
Case PC, Mitchell AJ, Swanson NA, et al. Topical therapy of alopecia areata with squaric acid dibutylester. J Am Acad Dermatol. 1984;10(3):447-50.
Case, P. C., Mitchell, A. J., Swanson, N. A., Vanderveen, E. E., Ellis, C. N., & Headington, J. T. (1984). Topical therapy of alopecia areata with squaric acid dibutylester. Journal of the American Academy of Dermatology, 10(3), 447-50.
Case PC, et al. Topical Therapy of Alopecia Areata With Squaric Acid Dibutylester. J Am Acad Dermatol. 1984;10(3):447-50. PubMed PMID: 6725657.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Topical therapy of alopecia areata with squaric acid dibutylester. AU - Case,P C, AU - Mitchell,A J, AU - Swanson,N A, AU - Vanderveen,E E, AU - Ellis,C N, AU - Headington,J T, PY - 1984/3/1/pubmed PY - 1984/3/1/medline PY - 1984/3/1/entrez SP - 447 EP - 50 JF - Journal of the American Academy of Dermatology JO - J Am Acad Dermatol VL - 10 IS - 3 N2 - The efficacy of the topical allergen squaric acid dibutylester (SADBE) was investigated in the treatment of twenty-six patients with alopecia areata or alopecia totalis. The patients had their disease for a mean duration of 8.3 years (range, 3 months to 27 years). Sensitization was attempted with 2% SADBE in acetone. Five individuals could not be sensitized. The twenty-one sensitized patients were treated with topical applications of 0.001% to 1.0% SADBE in acetone adjusted to produce and maintain dermatitis for an average of 21 weeks. Eleven (52%) had excellent responses consisting of complete regrowth in six and cosmetically acceptable regrowth in five. The average treatment time for regrowth was 11 weeks (range, 5-20 weeks). Ten (48%) had no clinical response after an average of 19 weeks of therapy (range, 4-42 weeks). Topical SADBE is an effective therapy for some patients with long-standing alopecia areata. SN - 0190-9622 UR - https://www.unboundmedicine.com/medline/citation/6725657/Topical_therapy_of_alopecia_areata_with_squaric_acid_dibutylester_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0190-9622(84)80091-2 DB - PRIME DP - Unbound Medicine ER -